Schrodinger Inc (STU:43Z)
€ 13.27 +0.095 (+0.72%) Market Cap: 984.53 Mil Enterprise Value: 728.12 Mil PE Ratio: 0 PB Ratio: 3.60 GF Score: 56/100

Schrodinger Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 06:05PM GMT
Unidentified Participant

Next up is Schrodinger. Schrodinger is a tech-enabled drug development company, I think, known for computational chemistry and a unique or an aspect of your business that I think is of interest and will cover is also have a portfolio of proprietary work, through partnerships or otherwise.

But I'm happy to be joined by Ramy Farid, CEO and Richie Jain, CFO. Thank you both for taking the time.

Ramy Farid
Schrodinger Inc - President, Chief Executive Officer, Director

Yeah, thanks for having us.

Richie Jain
Schrodinger Inc - Executive Vice President, Chief Financial Officer, Treasurer

Thank you. It's our first time attending this conference. So thank you for the invite.

Ramy Farid
Schrodinger Inc - President, Chief Executive Officer, Director

Great conference so far. Great.

Questions & Answers

Unidentified Participant

Well, glad to hear it. I wanted to start with just talking about the end market. Maybe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot